SCHEMBL22009316

SCHEMBL22009316

CC(CCCCSSSSCCCCC(C)CS(Cl)(Cl)Cl)CS(Cl)(Cl)Cl

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22008639 0.96 LMNA (0.30) LMNA
SCHEMBL22008640 0.94
SCHEMBL22008638 0.92 LMNA (0.32) LMNA
SCHEMBL22008637 0.85
SCHEMBL22008636 0.85
SCHEMBL22007733 0.77
SCHEMBL22008369 0.74 LMNA (0.35) LMNA
SCHEMBL22009318 0.72 ALDH1A1 (0.35) LMNA
SCHEMBL22008373 0.72 LMNA (0.31) LMNA
SCHEMBL6905110 0.67 LMNA (0.42) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200157317-A1 SULFUR CONTAINING ORGANOSILICON COMPOUND AND RESIN COMPOSITION KURARAY CO., LTD. (JP) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157317-A1 SULFUR CONTAINING ORGANOSILICON COMPOUND AND RESIN COMPOSITION MSRB3, RPS6, SEM1 LMNA 4797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.